IRX Therapeutics, Inc.

The progression of investigational products through a series of increasingly sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for commer

Company Changes ADAMS , Derek, PhD To: bluebird bio Inc. , Chief Technology & Mfg. Officer (March) From: Evelo Biosciences, SVP, CMC Phone: 339-499-9300 ARBET-ENGELS , Christophe, MD, PhD To:

The progression of investigational products through a series of increasingly more sophisticated and targeted clinical trials is a well-tried and tested route for the development of new medicines for c

IRX Therapeutics Inc. has appointed biotech industry veterans Mark Leuchtenberger and Monil Shah to president, CEO and director, and as chief operating officer, respectively . IRX’s founder